A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

被引：13

作者：

Thijssen, Vito ^{[1
,2
]}

Hurdiss, Daniel L. ^{[3
]}

Debski-Antoniak, Oliver J. ^{[3
]}

Spence, Matthew A. ^{[4
]}

Franck, Charlotte ^{[5
,6
]}

Norman, Alexander ^{[5
,6
]}

Aggarwal, Anupriya ^{[7
]}

Mokiem, Nadia J. ^{[8
,9
]}

van Dongen, David A. A. ^{[1
,8
,9
]}

Vermeir, Stein W. ^{[1
,2
]}

Liu, Minglong ^{[1
,2
]}

Li, Wentao ^{[3
]}

Chatziandreou, Marianthi ^{[3
]}

Donselaar, Tim ^{[3
]}

Du, Wenjuan ^{[3
]}

Drulyte, Ieva ^{[10
]}

Bosch, Berend-Jan ^{[3
]}

Snijder, Joost ^{[8
,9
]}

Turville, Stuart G. ^{[7
]}

Payne, Richard J. ^{[5
,6
]}

Jackson, Colin J. ^{[4
,11
,12
]}

van Kuppeveld, Frank J. M. ^{[3
]}

Jongkees, Seino A. K. ^{[1
,2
]}

机构：

[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Chem Biol & Drug Discovery, NL-3584 CG Utrecht, Netherlands

[2] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands

[3] Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Sect Virol,Div Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands

[4] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia

[5] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia

[6] Univ Sydney, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Sydney, NSW 2006, Australia

[7] Kirby Inst, Sydney, NSW 2052, Australia

[8] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands

[9] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands

[10] Thermo Fisher Sci, Mat & Struct Anal, NL-5651 GG Eindhoven, Netherlands

[11] Australian Natl Univ, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Canberra, ACT 2601, Australia

[12] Australian Natl Univ, Australian Res Council, Ctr Excellence Synthet Biol, Canberra, ACT 2601, Australia

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2023年 / 120卷 / 26期

基金：

澳大利亚研究理事会; 荷兰研究理事会; 比尔及梅琳达.盖茨基金会;

关键词：

macrocyclic peptides; mRNA display; SARS-CoV-2; antivirals; Cryo-EM; DISCOVERY; APTAMERS; DOMAIN;

D O I：

10.1073/pnas.2303292120

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The ongoing COVID-19 pandemic has had great societal and health consequences. Despite the availability of vaccines, infection rates remain high due to immune evasive Omicron sublineages. Broad-spectrum antivirals are needed to safeguard against emerging variants and future pandemics. We used messenger RNA (mRNA) display under a reprogrammed genetic code to find a spike-targeting macrocyclic peptide that inhibits SARS-CoV- 2 (severe acute respiratory syndrome coronavirus 2) Wuhan strain infection and pseudoviruses containing spike proteins of SARS-CoV- 2 variants or related sarbecoviruses. Structural and bioinformatic analyses reveal a conserved binding pocket between the receptor-binding domain, N-terminal domain, and S2 region, distal to the angiotensin-converting enzyme 2 receptor-interaction site. Our data reveal a hitherto unexplored site of vulnerability in sarbecoviruses that peptides and potentially other drug-like molecules can target.

引用

页数：7

共 50 条

[1] Design of the conserved epitope peptide of SARS-CoV-2 spike protein as the broad-spectrum COVID-19 vaccine
Chang, Ting-Yu
Li, Chia-Jung
Chao, Tai-Ling
Chang, Sui-Yuan
Chang, Shih-Chung
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 108 (01)
[2] Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Wu, Chung-Yi
Cheng, Cheng-Wei
Kung, Chih-Chuan
Liao, Kuo-Shiang
Jan, Jia-Tsrong
Ma, Che
Wong, Chi-Huey
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (09)
[3] FOUR POTENTIAL BROAD-SPECTRUM NEUTRALIZING EPITOPES IN THE SPIKE PROTEIN OF SARS-COV-2 PREDICTED BY BIOINFORMATICS
He, Yunyi
Zhang, Ning
Qu, Ying
Zhu, Hanyu
Liu, Qiliang
Liu, Hongbo
ACTA MEDICA MEDITERRANEA, 2021, 37 (03): : 1323 - 1329
[4] Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants
Ma, Jing
Huang, Yongdong
Jia, Guodong
Dong, Xiaoyan
Shi, Qinghong
Sun, Yan
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 283
[5] A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity
Ye, Guoguo
Tang, Yimin
Yang, Qin
Zhang, Chenhui
Shi, Huiping
Wang, Jun
Hu, Xiao
Wan, Xiaofu
Xu, Zhixiang
Liang, Jinhu
Yang, Yang
Yang, Minghui
Liu, Yingxia
JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
[6] A nanomolar potency macrocyclic peptide inhibitor of SARS-CoV-2 spike through deep mutational scanning
Hopstaken, Antonius
Debski-Antoniak, Oliver
Hooda, Preeti
Hurdiss, Daniel
Jongkees, Seino
JOURNAL OF PEPTIDE SCIENCE, 2024, 30
[7] A Broad-Spectrum Antimicrobial and Antiviral Membrane Inactivates SARS-CoV-2 in Minutes
Liu, Qingsheng
Zhang, Yidan
Liu, Wanjun
Wang, Long-Hai
Choi, Young W.
Fulton, Megan
Fuchs, Stephanie
Shariati, Kaavian
Qiao, Mingyu
Bernat, Victorien
Ma, Minglin
ADVANCED FUNCTIONAL MATERIALS, 2021, 31 (47)
[8] SARS-CoV-2 spike protein capture by peptide functionalized networks
Rahman, Monica S.
Rajawasam, Chamoni W. H.
Watuthanthrige, Nethmi De Alwis
Sparks, Jessica L.
Page, Richard C.
Konkolewicz, Dominik
JOURNAL OF POLYMER SCIENCE, 2023, 61 (05) : 391 - 397
[9] Study of fusion peptide release for the spike protein of SARS-CoV-2
Yu, Jie
Zhang, Zhi-Wei
Yang, Han-Yu
Liu, Chong-Jin
Lu, Wen-Cai
RSC ADVANCES, 2023, 13 (25) : 16970 - 16983
[10] From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
Ma, Cuiqing
Su, Shan
Wang, Jiachao
Wei, Lin
Du, Lanying
Jiang, Shibo
MICROBES AND INFECTION, 2020, 22 (6-7) : 245 - 253

← 1 2 3 4 5 →